Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ray Page

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Oncology Practice|May 14, 2016
A Pathway Through the Bundle JungleBlase Polite, Jeffery C Ward, John V Cox, et al.
Future Oncology (London, England)|November 16, 2021
Real-world ibrutinib dose reductions, holds and discontinuations in chronic lymphocytic leukemiaJing-Zhou Hou, Kellie Ryan, Senxi Du, et al.
JCO Oncology Practice|April 21, 2023
Biosimilar Use Among 38 ASCO PracticeNET Practices, 2019-2021Brian Bourbeau, Gary H Lyman, Xiudong Jennifer Lei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2019
Safe Handling of Hazardous Drugs: ASCO StandardsPaul Celano, Christopher A Fausel, Erin B Kennedy, et al.
Journal of Clinical Pathways : the Foundation of Value-Based Care|August 28, 2019
Patterns of Biomarker Testing Rates and Appropriate Use of Targeted Therapy in the First-Line, Metastatic Non-Small Cell Lung Cancer Treatment SettingCasey Mason, Peter G Ellis, Kathy Lokay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2005
Multicenter phase II trial of ABI-007, an albumin-bound paclitaxel, in women with metastatic breast cancerNuhad K Ibrahim, Brian Samuels, Ray Page, et al.
Clinical Lung Cancer|October 24, 2020
Nanoparticle Albumin-bound Paclitaxel Plus Carboplatin Induction Followed by Nanoparticle Albumin-bound Paclitaxel Maintenance in Squamous Non-Small-cell Lung Cancer (ABOUND.sqm): A Phase III Randomized Clinical TrialDavid R Spigel, Robert M Jotte, Santiago Ponce Aix, et al.
Journal for Immunotherapy of Cancer|October 28, 2021
Real-world performance of blood-based proteomic profiling in first-line immunotherapy treatment in advanced stage non-small cell lung cancerPatricia Rich, R Brian Mitchell, Eric Schaefer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 23, 2014
Phase II randomized trial comparing sequential first-line everolimus and second-line sunitinib versus first-line sunitinib and second-line everolimus in patients with metastatic renal cell carcinomaRobert J Motzer, Carlos H Barrios, Tae Min Kim, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 19, 2016
PD-L1 Expression by Two Complementary Diagnostic Assays and mRNA In Situ Hybridization in Small Cell Lung CancerHui Yu, Cory Batenchuk, Andrzej Badzio, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Oncology Practice|May 14, 2016
A Pathway Through the Bundle JungleBlase Polite, Jeffery C Ward, John V Cox, et al.
Future Oncology (London, England)|November 16, 2021
Real-world ibrutinib dose reductions, holds and discontinuations in chronic lymphocytic leukemiaJing-Zhou Hou, Kellie Ryan, Senxi Du, et al.
JCO Oncology Practice|April 21, 2023
Biosimilar Use Among 38 ASCO PracticeNET Practices, 2019-2021Brian Bourbeau, Gary H Lyman, Xiudong Jennifer Lei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2019
Safe Handling of Hazardous Drugs: ASCO StandardsPaul Celano, Christopher A Fausel, Erin B Kennedy, et al.
Journal of Clinical Pathways : the Foundation of Value-Based Care|August 28, 2019
Patterns of Biomarker Testing Rates and Appropriate Use of Targeted Therapy in the First-Line, Metastatic Non-Small Cell Lung Cancer Treatment SettingCasey Mason, Peter G Ellis, Kathy Lokay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2005
Multicenter phase II trial of ABI-007, an albumin-bound paclitaxel, in women with metastatic breast cancerNuhad K Ibrahim, Brian Samuels, Ray Page, et al.
Clinical Lung Cancer|October 24, 2020
Nanoparticle Albumin-bound Paclitaxel Plus Carboplatin Induction Followed by Nanoparticle Albumin-bound Paclitaxel Maintenance in Squamous Non-Small-cell Lung Cancer (ABOUND.sqm): A Phase III Randomized Clinical TrialDavid R Spigel, Robert M Jotte, Santiago Ponce Aix, et al.
Journal for Immunotherapy of Cancer|October 28, 2021
Real-world performance of blood-based proteomic profiling in first-line immunotherapy treatment in advanced stage non-small cell lung cancerPatricia Rich, R Brian Mitchell, Eric Schaefer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 23, 2014
Phase II randomized trial comparing sequential first-line everolimus and second-line sunitinib versus first-line sunitinib and second-line everolimus in patients with metastatic renal cell carcinomaRobert J Motzer, Carlos H Barrios, Tae Min Kim, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 19, 2016
PD-L1 Expression by Two Complementary Diagnostic Assays and mRNA In Situ Hybridization in Small Cell Lung CancerHui Yu, Cory Batenchuk, Andrzej Badzio, et al.
Pageof 2